Legal Representation
Attorney
Brian D. Gildea
USPTO Deadlines
Next Deadline
99 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
February 18, 2026
Extension Available
Until February 18, 2026
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jul 18, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 18, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jul 18, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 18, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 24, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 24, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 18, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Dec 2, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 22, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 22, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 22, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 19, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Nov 19, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 19, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 14, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 10, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| May 10, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
Class 042
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system field
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"